{"id":7653,"date":"2025-07-16T15:13:31","date_gmt":"2025-07-16T15:13:31","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=7653"},"modified":"2026-03-24T15:39:27","modified_gmt":"2026-03-24T15:39:27","slug":"drug-related-deaths-in-bulgaria-in-2024-data-from-national-registry","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/drug-related-deaths-in-bulgaria-in-2024-data-from-national-registry\/","title":{"rendered":"Drug-related deaths in Bulgaria in 2024 (data from National Registry)"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n
Prevalence of psychoactive substance use
Prevalence of medication use
Prevalence of drug use<\/a>
Drug prevention
Treatment supply<\/a>
Treatment demand
Health consequences<\/a>
Harm reduction<\/a>
Drug-related crimes<\/a>
Drug market<\/a>
Drug use and prison<\/a>
Monitoring of publications<\/a>
Attitudes to legal framework changes<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

F11 – Mental and behavioural disorders due to use of opioids.<\/p>\n\n\n\n

X41 – Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism, and psychotropic drugs, not elsewhere classified.<\/p>\n\n\n\n

X42 – Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified.<\/p>\n\n\n\n

X62 – Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified<\/p>\n\n\n\n

Y12 – Poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified, undetermined intent.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Data for 2023<\/a><\/strong><\/p>\n\n\n\n

Data for 2022<\/a><\/strong><\/p>\n<\/div>\n\n\n\n

\n
<\/td>Total<\/strong><\/td>Males<\/strong><\/td>Females<\/strong><\/td><\/tr>
Number of drug-related deaths<\/strong><\/td>48<\/strong><\/td>42<\/strong><\/td>6<\/strong><\/td><\/tr>
Rates per 100,000 population<\/td>0.75<\/td>1.36<\/td>0.18<\/td><\/tr>
of which: <\/td><\/td><\/td><\/td><\/tr>
number of cases with opioids<\/td>17<\/td>15<\/td>2<\/td><\/tr>
By ICD-10 Codes (numbers):<\/strong><\/td><\/td><\/td><\/td><\/tr>
F11<\/td>3<\/td>3<\/td>0<\/td><\/tr>
X41<\/td>3<\/td>3<\/td>0<\/td><\/tr>
X42<\/td>27<\/td>24<\/td>3<\/td><\/tr>
x62<\/td>1<\/td>1<\/td>0<\/td><\/tr>
Y12<\/td>14<\/td>11<\/td>3<\/td><\/tr>
By age groups<\/strong><\/td><\/td><\/td><\/td><\/tr>
< 20<\/td>1<\/td>0<\/td>1<\/td><\/tr>
20-24<\/td>4<\/td>4<\/td>0<\/td><\/tr>
25-29<\/td>1<\/td>1<\/td>0<\/td><\/tr>
30-34<\/td>3<\/td>3<\/td>0<\/td><\/tr>
35-39<\/td>12<\/td>11<\/td>1<\/td><\/tr>
40-44<\/td>15<\/td>11<\/td>4<\/td><\/tr>
45-49<\/td>10<\/td>10<\/td>0<\/td><\/tr>
50-54<\/td>1<\/td>1<\/td>0<\/td><\/tr>
55-59<\/td>1<\/td>1<\/td>0<\/td><\/tr>
60-64<\/td>0<\/td>0<\/td>0<\/td><\/tr>
>= 65<\/td>0<\/td>0<\/td>0<\/td><\/tr>
Mean age<\/strong><\/td>39.1<\/td>39.5<\/td>36.5<\/td><\/tr><\/tbody><\/table>
Source: National Statistical Institute<\/em><\/figcaption><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Prevalence of psychoactive substance usePrevalence of medication usePrevalence of drug useDrug preventionTreatment supplyTreatment demandHealth consequencesHarm reductionDrug-related crimesDrug marketDrug use and prisonMonitoring of publicationsAttitudes to legal framework changes F11 – Mental and behavioural disorders due to use of opioids. X41 – Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism, and psychotropic drugs, not elsewhere classified. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,86],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7653"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=7653"}],"version-history":[{"count":3,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7653\/revisions"}],"predecessor-version":[{"id":7657,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7653\/revisions\/7657"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=7653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=7653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=7653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}